Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA

Hongguan Biopharmaceutical Co., Ltd., established on 2013-04-02, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Import and export;Technology Import and Export;Chemical product production(No licensed chemical products);Chemical product sales(No licensed chemical products);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Industrial Design Services(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Nanjing Changao Pharmaceutical Science & Technology Co. Ltd., a subsidiary of Shionogi & Co., Ltd., is a Chinese company located in Nanjing that manufactures and distributes pharmaceutical products. On January 11, 2006 C&O Pharmaceutical Technology (Holdings) Ltd., now a subsidiary of Shionogi & Co., Ltd. acquired Nanjing Changao Pharmaceutical Science & Technology Co. Ltd. for $0.09 million.

Shanghai Zhaohui Pharmaceutical Co., Ltd., established on 1988-03-23, Business scope includes pharmaceutical production(See the license for details);Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

CELLPROTEK provides small molecule drugs for the treatment of major diseases of the central nervous system. They also create medications for acute ischemia stroke, alzheimer's disease, cardiovascular, cerebrovascular, and neurodegenerative diseases.

Minsheng Pharmaceutical is a chemical pharmaceutical factory. The company produces four categories of products is prescription drugs, including anti-cancer, anti-hepatitis, and cardiovascular drugs. OTC, large volume parenteral and active pharmaceutical ingredients.

INHA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION provides practical help for improving the technology of an industrial field.

Nippon Shinyaku Co., Ltd. engages in the manufacture and sale of pharmaceuticals and foodstuffs. Its operations are carried out through the Pharmaceuticals and Functional Food divisions. The Pharmaceuticals division develops and distributes drugs that treat urological diseases, inflammation, allergies, hematological malignancies, cardiovascular and metabolic diseases, and gastrointestinal disorders. The Functional Food division manufactures and supplies health food ingredients, preservatives, protein preparations, nutritional ingredients, seasonings and spices, and sterilization cleaning agents. The company was founded on November 20, 1911 and is headquartered Kyoto, Japan.

Changzhou Ruiming Pharmaceutical Co., Ltd., established on 2005-04-22, Business scope includes pharmaceutical manufacturing,Sales(The operating permit);Manufacture of p-Hydroxyphenylacetone,Sales;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Green Bamboo involves in the research of biotechnology drugs and infectious disease detection reagents. Their products such as k193 antibody injection, recombinant herpes zoster vaccine, anti-human tumor necrosis factor-α monoclonal antibody injection, recombinant varicella vaccine, recombinant rabies vaccine, k333 antibody injection, and ek193 antibody injection.

Minsheng Group Shaoxing Pharmaceutical Co., Ltd. engages in pharmaceutical innovation and drug research and development. The company produces more than 20 kinds of chemical synthesis, extractive semi-synthetic pharmaceutical raw materials from plants. The company was founded on April 18, 2016 and is headquartered in Shaoxing, China.

Produces and distributes cosmetics, toiletries, textiles and food products

Angelini produces, markets and distributes products for the health and well-being of people. Being close to the people and meeting their daily needs with effective and reliable products, of high quality, of great diffusion and accessibility, guaranteeing a constant and tangible well-being is the mission of Angelini. His goal is expressed in a clear vision: to be the spontaneous choice in the area of ​​health and daily well-being.

Yancheng Green Chemical Co., Ltd., established on 2008-04-18, Business scope includes polyepoxysuccinic acid,Phosphonocarboxylic acid cotelomer,Polyamino polyether methylene phosphate,Composite Water Stabilizer,3,5-Dimethylpyrazole,5-Trifluoromethyluracil,sodium hydroxide solution[content<30%],Glycidyl methacrylate,2,4-benzaldehyde disulfonate,3-hydroxyl-2-Phenylpropionic acid,N-(4-picolyl methyl)Production of ethylamine,And sell self-produced products in the factory area;General hazardous chemicals:hydrogen chloride[Anhydrous],ammonia,Triethylamine,1-chlorine-2,3-Propylene oxide,benzene,formaldehyde solution,2,4-Pentadione,sodium hydroxide solution[Content ≥30%],2-Isooctyl acrylate;precursor chemicals:hydrochloric acid,Management of toluene.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

The Istituto Superiore di Sanità (Italian National Institute of Health), also ISS, is an Italian public institution that, as the leading technical-scientific body of the Italian National Health Service (Servizio Sanitario Nazionale), performs research, trials, control, counseling, documentation and training for public health. The Institute is under the supervision of the Ministero della Salute (Ministry of Health).